Navigation Links
Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi

A new study says that symptoms associated with ovarian cancer start much earlier before the diagnosis// is made and being alert to these symptoms could make a huge difference in the rapid treatment of the cancer. Ovarian cancer is more curable if detected early enough.

The study team led by Dr. Lloyd H. Smith from the University of California Davis Health System in Sacramento says that their observations 'provide objective evidence that patients with ovarian cancer, as a group, are distinguishable symptomatically from controls at least 6 months prior to diagnosis.'

The team monitored the pattern of appearance of the symptoms like abdominal bloating and pain, and the associated diagnostic tests in 1,900 with Ovarian cancer and 6,000 women with breast cancer, and 11,000 women without cancer. The team arrived at the conclusion that women with ovarian cancer were more likely to have 'target symptoms' like the abdominal pain and bloating around six months before the diagnosis was confirmed. The team also found that abdominal imaging and pelvic imaging with CA125 testing was common around 3 months before diagnosis, but the same was lacking 4 to 36 months prior to diagnosis. CA125 is a protein whose levels are increased in ovarian cancer. 'Our findings suggest that ovarian cancer could be diagnosed earlier in some patients whose diagnosis is currently delayed by at least 4 months, because physicians order abdominal imaging or perform gastrointestinal procedures before they order a test that is more likely to diagnose ovarian cancer, such as pelvic imaging and/or CA125,' the authors conclude. The details of the study are published in the October 1 issue of the journal Cancer.


'"/>




Page: 1

Related medicine news :

1. Ovarian cancer in relationship with Hormone therapy
2. Exercise lowers Risk of Ovarian Cancer
3. Gene Mutation Causes Ovarian Failure
4. Ovarian Cancer Screening Questioned
5. Thawed Ovarian Transplant
6. The Benefits Of Chemotherapy For Women With Ovarian Cancer
7. Progesterone Found To Increase Ovarian Cancer Risk
8. Developmental Origins of Polycystic Ovarian Syndrome
9. Polycystic Ovarian Syndrome(PCOS) linked to Diabetes
10. Ovarian cancer risk reduced by regular exercise
11. Genetic Profile To Predict Ovarian Cancer Prognosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... NJ (PRWEB) , ... May 26, 2016 , ... ... recognized as an NJ Top Doc! Along with his wonderful accolades and stellar ... in podiatry. Congratulations, Dr. Batelli! , Dr. Eugene Batelli is a highly ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, ... the first PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led ... professional through the 8 hour interactive course to qualify participants as certified PowerWave ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie , the manufacturer ... treatment was more than humbled by customer demand over the Mother’s Day Weekend promotion. ... sale. Now that Bunion Bootie has completely replenished its inventory levels, it hopes to ...
(Date:5/26/2016)... ... May 26, 2016 , ... OncLive® , a ... Cancer Institute-designated University of Virginia (UVA) Cancer Center to its quickly ... and marketing teams will publicize and promote public awareness of UVA Cancer Center’s ...
(Date:5/26/2016)... ... May 26, 2016 , ... On May 23rd during the National Eye ... and international water advocate, was honored by Ashram, Inc. as the world’s foremost water ... knelt on the banks of the Nile to fill their red clay pots with ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 Since ... matured into an essential life science tool for conducting ... applications. BCC Research reveals in its new report that ... growth phase, one powered by a range of new ...      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
(Date:5/25/2016)... 25, 2016 According to a ... (3D, 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), ... (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021", ... Animation Market for the forecast period of 2016 to ... Million by 2021 from USD 117.3 Million in 2016, ...
Breaking Medicine Technology: